Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression Hildegund C. J. Ertl Leading Article 30 January 2023 Pages: 287 - 298
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases Paulina NúñezRodrigo QueraAndres J. Yarur Review Article Open access 13 March 2023 Pages: 299 - 314
Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019 Vincent K. C. YanHang-Long LiEsther W. Chan Original Research Article 25 February 2023 Pages: 315 - 340
Etranacogene Dezaparvovec: First Approval Young-A Heo AdisInsight Report 21 February 2023 Pages: 347 - 352
Nadofaragene Firadenovec: First Approval Arnold Lee AdisInsight Report Open access 01 March 2023 Pages: 353 - 357
